Get Real Time Here
| Open0.196 | Close0.195 |
| Vol / Avg.136.446K / 1.170M | Mkt Cap8.370M |
| Day Range0.181 - 0.203 | 52 Wk Range0.134 - 1.300 |
Applied Molecular Stock (NASDAQ:AMTI), Quotes and News Summary
Applied Molecular Stock (NASDAQ: AMTI) stock price, news, charts, stock research, profile.
| Open0.196 | Close0.195 |
| Vol / Avg.136.446K / 1.170M | Mkt Cap8.370M |
| Day Range0.181 - 0.203 | 52 Wk Range0.134 - 1.300 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.170 | 0.3300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-28 | Chardan Capital | Matthew Barcus | Downgrades | BuyNeutral | - | - | - |
| 2023-03-06 | Chardan Capital | Matthew Barcus | Reiterates | Buy | Maintains | - | 3.00 |
| 2023-02-08 | Jefferies | Chris Howerton | Downgrades | HoldUnderperform | Lowers | 0.80 | 0.40 |
| 2023-01-05 | B of A Securities | Jason Gerberry | Downgrades | BuyUnderperform | Lowers | 5.00 | 0.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AMTI | Applied Molecular | 1.47% | 8.4M |
| ALZN | Alzamend Neuro | 1.92% | 6.9M |
| IMNN | Imunon | -2.25% | 8.2M |
| GOVX | Geovax Labs | 2.54% | 10.7M |
| BRTX | BioRestorative Therapies | 7.95% | 8.9M |
How do I buy Applied Molecular (AMTI) stock?
You can purchase shares of Applied Molecular (NASDAQ: AMTI) through any online brokerage.
Who are Applied Molecular's (AMTI) competitors?
Other companies in Applied Molecular’s space includes: Alzamend Neuro (NASDAQ:ALZN), Imunon (NASDAQ:IMNN), Geovax Labs (NASDAQ:GOVX), BioRestorative Therapies (NASDAQ:BRTX) and Finch Therapeutics Gr (NASDAQ:FNCH).
What is the target price for Applied Molecular (AMTI) stock?
The latest price target for Applied Molecular (NASDAQ: AMTI) was reported by Chardan Capital on Tuesday, March 28, 2023. The analyst firm set a price target for 0.00 expecting AMTI to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Applied Molecular (AMTI)?
The stock price for Applied Molecular (NASDAQ: AMTI) is $0.2 last updated December 6, 2023 at 9:31 PM UTC.
Does Applied Molecular (AMTI) pay a dividend?
There is no dividend information for Applied Molecular.
When is Applied Molecular (NASDAQ:AMTI) reporting earnings?
Applied Molecular’s Q4 earnings are confirmed for Thursday, March 7, 2024.
Is Applied Molecular (AMTI) going to split?
There is no upcoming split for Applied Molecular.
What sector and industry does Applied Molecular (AMTI) operate in?
Applied Molecular is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.